🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Renaissance Technologies (RenTech)’s CRMD Holdings & Trades

First Buy
Q4 2019
Duration Held
23 Quarters
Largest Add
Q2 2025
+152,200 Shares
Current Position
54,577 Shares
$420,243 Value

Renaissance Technologies (RenTech)'s CRMD Position Overview

Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 54,577 shares of CorMedix Inc. (CRMD) worth $420,243, representing 0.00% of the portfolio. First purchased in 2019-Q4, this long-term strategic position has been held for 23 quarters.

Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in CRMD, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 152,200 shares. Largest reduction occurred in Q2 2023, reducing 181,724 shares.

Analysis based on 13F filings available since 2013 Q2

Renaissance Technologies (RenTech)'s CorMedix (CRMD) Holding Value Over Time

Track share changes against reported price movement

Quarterly CorMedix (CRMD) Trades by Renaissance Technologies (RenTech)

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +54,577 New Buy 54,577 $7.70
Q3 2025 -152,200 Sold Out 0 $0.00
Q2 2025 +152,200 New Buy 152,200 $12.32
Q1 2025 -134,000 Sold Out 0 $0.00
Q4 2024 +134,000 New Buy 134,000 $8.10
Q3 2024 -160,734 Sold Out 0 $0.00
Q2 2024 -77,925 Reduce 32.65% 160,734 $4.33
Q1 2024 +2,959 Add 1.26% 238,659 $4.24
Q4 2023 +129,100 Add 121.11% 235,700 $3.76
Q3 2023 +106,600 New Buy 106,600 $3.70
Q2 2023 -181,724 Sold Out 0 $0.00
Q1 2023 +108,124 Add 146.91% 181,724 $0.00
Q4 2022 +60,000 Add 441.18% 73,600 $0.00
Q3 2022 +13,600 New Buy 13,600 $2.79
Q2 2022 -10,157 Sold Out 0 $0.00
Q1 2022 +10,157 New Buy 10,157 $5.51
Q4 2021 -118,001 Sold Out 0 $0.00
Q3 2021 +118,001 New Buy 118,001 $4.65
Q1 2021 -43,700 Sold Out 0 $0.00
Q4 2020 +43,700 New Buy 43,700 $7.44
Q2 2020 -128,900 Sold Out 0 $0.00
Q1 2020 +72,500 Add 128.55% 128,900 $3.59
Q4 2019 +56,400 New Buy 56,400 $7.29

Renaissance Technologies (RenTech)'s CorMedix Investment FAQs

Renaissance Technologies (RenTech) first purchased CorMedix Inc. (CRMD) in Q4 2019, acquiring 56,400 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Renaissance Technologies (RenTech) has held CorMedix Inc. (CRMD) for 23 quarters since Q4 2019.

Renaissance Technologies (RenTech)'s largest addition to CorMedix Inc. (CRMD) was in Q2 2025, adding 152,200 shares worth $1.88 M.

According to the latest 13F filing for Q3 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 54,577 shares of CorMedix Inc. (CRMD), valued at approximately $420,243.

As of the Q3 2026 filing, CorMedix Inc. (CRMD) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.

Renaissance Technologies (RenTech)'s peak holding in CorMedix Inc. (CRMD) was 238,659 shares, as reported at the end of Q1 2024.